Radiogenomic models using MRI features from multiple public datasets predicted the M0 macrophage immune signature in IDH-wildtype glioblastoma with mean balanced accuracy 0.67 and precision 0.89 on held-out cohorts.
Regulatable interleukin-12 gene therapy in patients with recurrent high -grade glioma: Results of a phase 1 trial
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
cs.LG 1years
2026 1verdicts
CONDITIONAL 1representative citing papers
citing papers explorer
-
Predictive Radiomics for Evaluation of Cancer Immune SignaturE in Glioblastoma: the PRECISE-GBM study
Radiogenomic models using MRI features from multiple public datasets predicted the M0 macrophage immune signature in IDH-wildtype glioblastoma with mean balanced accuracy 0.67 and precision 0.89 on held-out cohorts.